𝔖 Bobbio Scriptorium
✦   LIBER   ✦

1736 – Long-acting injectable risperidone and oral antipsychotics in patients with schizophrenia - a prospective one-year non-interventional study (inors)

✍ Scribed by Schreiner, A.; Svensson, A.; Wapenaar, R.; Cherubin, P.; Princet, P.; Serazetdinova, L.; Starostina, N.; Zink, M.


Book ID
122748388
Publisher
Elsevier Science
Year
2013
Tongue
French
Weight
46 KB
Volume
28
Category
Article
ISSN
0924-9338

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES


Remission in schizophrenia: one-year Ita
✍ Alessandro Rossi; Anna Bagalà; Vincenzo Del Curatolo; Francesco Scapati; Micaela 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 155 KB 👁 1 views

## Abstract ## Objectives To evaluate the maintenance of efficacy of risperidone long‐acting injectable (RLAI) in stable patients with schizophrenia or schizoaffective disorders. The prevalence of patients who met standardized remission criteria will be also evaluated as well as the predictors fac